Thus, recurrent glioblastoma shows a higher frequency of copy number variations in several genes, particularly cell cycle genes, an enrichment in the cyclin-dependent kinase inhibitor 2A/B (CDKN2A/B) loss, and an excessive activation of cell cycle pathway genes. Here, CDKN2A is linked to glioblastoma.